ClinicalTrials.Veeva

Menu

IRIS Ultimaster Cohort in the IRIS-DES Registry (IRISUltimaster)

D

Duk-Woo Park, MD

Status

Completed

Conditions

Coronary Artery Disease

Treatments

Device: Ultimaster stent

Study type

Observational

Funder types

Other

Identifiers

NCT02719106
AMCCV2016-05

Details and patient eligibility

About

The purpose of this study is to evaluate the relative effectiveness and safety of Ultimaster stent compared to other drug eluting stents.

Enrollment

1,000 patients

Sex

All

Ages

19+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age 19 and more
  • Intervention with Ultimaster stent
  • Agreed with written informed consent form

Exclusion criteria

  • Intervention with Ultimaster stent and other drug eluting stent at the same time
  • Life expectancy of 1year and under
  • Cardiac shock

Trial design

1,000 participants in 1 patient group

Ultimaster stent
Treatment:
Device: Ultimaster stent

Trial contacts and locations

15

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems